| 生物活性 |
Daplusiran is a siRNA in JNJ-3989 (JNJ-73763989). JNJ-3989 is comprised of 2 siRNAs (Daplusiran and Tomligisiran), that target hepatitis B virus (HBV) mRNAs for degradation, thereby inhibiting HBV replication.
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 分子式 |
C492H650F12N163O310P43S7
|
||||||||||||
| 分子量 |
15591.6
|
||||||||||||
| CAS号 |
2202783-35-3
|
||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
||||||||||||
| 储存方式 |
|
关注我们
获得KKL MED 最新资讯
咨询热线：
400-881-9290
Data Sheet